ATXS
Price
$7.30
Change
+$0.15 (+2.10%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
411.97M
46 days until earnings call
ZIVO
Price
$13.91
Change
+$0.91 (+7.00%)
Updated
Sep 25 closing price
Capitalization
53.09M
Interact to see
Advertisement

ATXS vs ZIVO

Header iconATXS vs ZIVO Comparison
Open Charts ATXS vs ZIVOBanner chart's image
Astria Therapeutics
Price$7.30
Change+$0.15 (+2.10%)
Volume$3.97K
Capitalization411.97M
Zivo Bioscience
Price$13.91
Change+$0.91 (+7.00%)
Volume$110
Capitalization53.09M
ATXS vs ZIVO Comparison Chart in %
Loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZIVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATXS vs. ZIVO commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a Buy and ZIVO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (ATXS: $7.30 vs. ZIVO: $13.91)
Brand notoriety: ATXS and ZIVO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 90% vs. ZIVO: 9%
Market capitalization -- ATXS: $411.97M vs. ZIVO: $53.09M
ATXS [@Biotechnology] is valued at $411.97M. ZIVO’s [@Biotechnology] market capitalization is $53.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileZIVO’s FA Score has 0 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • ZIVO’s FA Score: 0 green, 5 red.
According to our system of comparison, ATXS is a better buy in the long-term than ZIVO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 4 TA indicator(s) are bullish while ZIVO’s TA Score has 5 bullish TA indicator(s).

  • ATXS’s TA Score: 4 bullish, 6 bearish.
  • ZIVO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ZIVO is a better buy in the short-term than ATXS.

Price Growth

ATXS (@Biotechnology) experienced а +3.55% price change this week, while ZIVO (@Biotechnology) price change was +6.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

ATXS is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATXS($412M) has a higher market cap than ZIVO($53.1M). ATXS YTD gains are higher at: -18.345 vs. ZIVO (-35.302). ZIVO has higher annual earnings (EBITDA): -9.7M vs. ATXS (-131.42M). ATXS has more cash in the bank: 259M vs. ZIVO (9.82K). ZIVO has less debt than ATXS: ZIVO (779K) vs ATXS (4.77M). ZIVO has higher revenues than ATXS: ZIVO (175K) vs ATXS (0).
ATXSZIVOATXS / ZIVO
Capitalization412M53.1M776%
EBITDA-131.42M-9.7M1,355%
Gain YTD-18.345-35.30252%
P/E RatioN/AN/A-
Revenue0175K-
Total Cash259M9.82K2,636,669%
Total Debt4.77M779K612%
FUNDAMENTALS RATINGS
ATXS vs ZIVO: Fundamental Ratings
ATXS
ZIVO
OUTLOOK RATING
1..100
699
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
78
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
4591
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5036

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATXS's Valuation (55) in the Biotechnology industry is in the same range as ZIVO (78) in the null industry. This means that ATXS’s stock grew similarly to ZIVO’s over the last 12 months.

ATXS's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ZIVO (100) in the null industry. This means that ATXS’s stock grew similarly to ZIVO’s over the last 12 months.

ATXS's SMR Rating (98) in the Biotechnology industry is in the same range as ZIVO (100) in the null industry. This means that ATXS’s stock grew similarly to ZIVO’s over the last 12 months.

ATXS's Price Growth Rating (45) in the Biotechnology industry is somewhat better than the same rating for ZIVO (91) in the null industry. This means that ATXS’s stock grew somewhat faster than ZIVO’s over the last 12 months.

ATXS's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ZIVO (100) in the null industry. This means that ATXS’s stock grew similarly to ZIVO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATXSZIVO
RSI
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
74%
MACD
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 23 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
81%
Aroon
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZIVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGHRX77.47N/A
N/A
Morgan Stanley Inst Growth IR
APXYY0.38N/A
N/A
Appen Ltd.
DELHY2.87N/A
N/A
Delivery Hero AG NA
MTPVY15.00N/A
N/A
Metropole Television SA
IRCKF0.59N/A
N/A
Inter-Rock Minerals, Inc.

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with CRNX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
+2.10%
CRNX - ATXS
53%
Loosely correlated
+27.92%
DNLI - ATXS
51%
Loosely correlated
+3.87%
XENE - ATXS
51%
Loosely correlated
+4.00%
VRDN - ATXS
51%
Loosely correlated
+5.77%
NRIX - ATXS
50%
Loosely correlated
+7.20%
More

ZIVO and

Correlation & Price change

A.I.dvisor tells us that ZIVO and MDXXF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZIVO and MDXXF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZIVO
1D Price
Change %
ZIVO100%
N/A
MDXXF - ZIVO
22%
Poorly correlated
-2.18%
ATXS - ZIVO
21%
Poorly correlated
+2.10%
COGT - ZIVO
20%
Poorly correlated
+6.55%
CLSD - ZIVO
20%
Poorly correlated
+8.31%
ATHA - ZIVO
15%
Poorly correlated
+1.31%
More